Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information
Search results for: Gout
Mind-Body Focus Can Improve Treatment, Outcomes in Rheumatic Disease
Recognizing psychological effects of chronic conditions can help rheumatologists implement multidisciplinary approach to patient care
Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure
NIAMS’ Intramural Research Programs Foster Spirit of Discovery
National Institute of Arthritis and Musculoskeletal and Skin Diseases program recognized for excellence in training, innovation
2014 ACR/ARHP Annual Meeting: Innate Immunity at the Core of Rheumatic Disease
Rheumatology Research Foundation Memorial Lectureship honors work of renowned rheumatologist Stephen Malawista, MD
Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate
Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
Rheumatology Fellows-in-Training Offer Fresh Perspectives on the ACR/ARHP Annual Meeting
Medical residents relay insights on annual meeting sessions, lectures, networking events, and Boston tourism
The Rheumatologist as Detective
A case of difficult-to-diagnose Whipple’s disease
2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Plus, hydrocodone combination products and brodalumab
Coding Corner Answers: January
Proper coding for cases of drug-induced gout, systemic lupus erythematosus with lung involvement, inflammatory rheumatoid arthritis, osteoporosis
- « Previous Page
- 1
- …
- 42
- 43
- 44
- 45
- 46
- …
- 60
- Next Page »